Compositions and methods for treatment of ocular diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11058750
APP PUB NO 20180271958A1
SERIAL NO

15780294

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Use of activated protein C (APC) for treatment and prevention of ocular diseases, disorders or conditions associated with retinal leakage and CNV such as age-related macular degeneration, optionally in combined therapy with anti-angiogenesis, anti-inflammatory, immunosuppressive, and anti PDGF agent.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • MOR RESEARCH APPLICATIONS LTD

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Livnat, Tami Savyon, IL 2 0
Nisgav, Yael Ramat Hasharon, IL 6 12
Weinberger, Dov Tel Aviv, IL 3 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jan 13, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 13, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 13, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00